II
BEAM icon

Ishara Investments’s Beam Therapeutics BEAM Stock Holding History

Ishara Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Sell
41,000
-16,400
-29% -$495K 1.03% 30
2026
Q1 		$1.37M Buy
57,400
+7,400
+15% +$205K 1.3% 30
2025
Q4 		$1.39M Buy
+50,000
New +$1.28M 1.58% 23

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Ishara Investments's BEAM Position: Q2 2026 in Review

Ishara Investments reduced its Beam Therapeutics (BEAM) stake by 29% in Q2 2026, selling an estimated $495K and leaving 41,000 shares worth $1.41M. The position accounts for 1.03% of the portfolio, ranked #30.

Ishara Investments first reported a position in BEAM in Q4 2025 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Ishara Investments held 41,000 shares of Beam Therapeutics worth $1.41M as of Q2 2026.
  • Ishara Investments sold 16,400 Beam Therapeutics shares in Q2 2026, an estimated $495K.
  • Beam Therapeutics made up 1.03% of Ishara Investments's portfolio in Q2 2026, its #30 holding.
  • Ishara Investments first reported a position in Beam Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.